Search

Your search keyword '"Rivas, José"' showing total 776 results

Search Constraints

Start Over You searched for: Author "Rivas, José" Remove constraint Author: "Rivas, José" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
776 results on '"Rivas, José"'

Search Results

2. The global distribution and drivers of wood density and their impact on forest carbon stocks

4. Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease

7. Integrated global assessment of the natural forest carbon potential

8. The global biogeography of tree leaf form and habit

10. Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial

11. Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)

12. Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study

13. Translation and validation of the Revised Attitudes Toward Research Scale (R-ATR) in Peruvian university students /Traducción y validación de la Escala de Actitudes hacia la Investigación Revisada (R-ATR) en estudiantes universitarios peruanos /Traducão e validacão da Escala de Atitudes de Pesquisa Revisada (R-ATR) em estudantes universitários peruanos /Traduction et validation de l'échelle révisée des attitudes envers la recherche (R-ATR) chez des étudiants universitaires péruviens

14. Native diversity buffers against severity of non-native tree invasions

17. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

23. SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination

25. One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

27. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

28. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

29. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

30. Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

32. Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey

33. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

34. Co-limitation towards lower latitudes shapes global forest diversity gradients

37. Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study

38. Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients

39. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

40. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

41. Natural variations in AAVHSC16 significantly reduce liver tropism and maintain broad distribution to periphery and CNS

43. Evaluation of Two-Dimensional DBH Estimation Algorithms Using TLS.

44. Transcriptomic Analysis During Olive Fruit Development and Expression Profiling of Fatty Acid Desaturase Genes.

47. Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study

49. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

50. Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

Catalog

Books, media, physical & digital resources